Moscow, Russia

Maria Tsyuruoa


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:

goldMedal1 out of 3 
 
Medasorb Corporation
 patents
silverMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Tsyuruoa: Innovator in Biocompatible Devices

Introduction

Maria Tsyuruoa is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biocompatible devices, particularly in the development of systems and methods aimed at reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood. Her innovative work addresses critical health issues related to inflammation and its associated diseases.

Latest Patents

Maria Tsyuruoa holds a patent for her invention titled "Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood." This patent describes devices, systems, and methods that utilize selective adsorption to reduce abnormal levels of inflammatory mediators in the blood. The technology is particularly useful in situations where there is excessive interaction among these stimulators, helping to prevent, control, and alleviate inflammatory responses and related disease states.

Career Highlights

Throughout her career, Maria has worked with various organizations, including Medasorb Corporation. Her expertise in biocompatible technologies has positioned her as a leader in her field, contributing to advancements that have the potential to improve patient outcomes in inflammatory conditions.

Collaborations

Maria has collaborated with notable professionals in her field, including James A. Brady and James Edward Winchester. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in biocompatible device technology.

Conclusion

Maria Tsyuruoa's work in biocompatible devices represents a significant advancement in medical technology. Her innovative approaches to managing inflammation through selective adsorption have the potential to transform treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…